FDA Approvals

FDA Approves Leucovorin for Rare Neurological Disorder Touted in Autism Debate

The Food and Drug Administration approved leucovorin, a drug the Trump administration has touted as a potential therapy for autism, to treat cerebral folate transport deficiency — a rare neurological disorder with some symptoms similar to autism.